Viking Therapeutics (VKTX)
(Delayed Data from NSDQ)
$66.47 USD
-1.48 (-2.18%)
Updated Apr 17, 2024 04:00 PM ET
After-Market: $66.47 0.00 (0.00%) 5:46 PM ET
3-Hold of 5 3
C Value C Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
04/24/2024
Time: -- |
3/2024 | $-0.27 | 0.00% |
Earnings Summary
For their last quarter, Viking Therapeutics (VKTX) reported earnings of -$0.25 per share, in line with the Zacks Consensus Estimate. This reflects a breakeven earnings surprise. Look out for VKTX's next earnings release expected on April 24, 2024. For the next earning release, we expect the company to report earnings of -$0.27 per share, reflecting a year-over-year decrease of 8%.
Earnings History
Price & Consensus
Zacks News for VKTX
Zacks Investment Ideas feature highlights: SPDR S&P Biotech ETF, iShares Biotech ETF, Viking Therapeutics and Madrigal Pharmaceuticals
VKTX: What are Zacks experts saying now?
Zacks Private Portfolio Services